Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts
Pfizer shares fell 3.4% to $25.53 late Dec. 16 after the company issued 2026 guidance projecting flat-to-declining revenue and adjusted EPS of $2.80–$3.00. The outlook cited lower COVID product sales and a $1.5 billion hit from patent expirations. Pfizer expects no share buybacks through 2026. Wall Street noted the EPS target is slightly below consensus.